Statements of Operations - USD ($)	12 Months Ended
	Dec. 31, 2015	Dec. 31, 2014
Revenue
Product sales	$ 6,448,910	$ 6,190,698
Cost of product sales	2,634,700	3,155,288
Gross profit	3,814,210	3,035,410
Operating expenses
Research and development	1,378,807	871,100
Sales and marketing	2,583,731	1,329,746
General and administrative	4,868,801	3,970,254
Total operating expenses	8,831,339	6,171,100
Operating loss	(5,017,129)	(3,135,690)
Other income (expenses)
Interest income	21,753	20,825
Interest expense	0	(177,308)
Amortization of deferred financing costs	0	(13,022)
Gain on disposal of property and equipment	0	4,400
Total other income (expenses)	21,753	(165,105)
Net Loss	(4,995,376)	(3,300,795)
Net loss attributable to non-controlling interest	781,440	83,045
Net Loss attributable to BioLife Solutions, Inc.	$ (4,213,936)	$ (3,217,750)
Basic and diluted net loss per common share	$ (0.35)	$ (0.31)
Basic and diluted weighted average common shares used to calculate net loss per common share	12,177,396	10,447,030